| Pharmaceutical active ingredients: |
| Tripotassium Dicitratobismuthate |
| Available forms, composition and doses of Lacertral: |
| N / A |
| Lacertral medical category: |
| Human:Antacids, antireflux agents and antiulcerants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A02BX05 - Bismuth Subcitrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Lacer |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
De-Nol | Tripotassium Dicitratobismuthate | Yamanouchi; Astellas Pharma; Brocades Pharma; CSL; Gerolymatos; Indrugco; Perrigo; Pharma-Regist; Primal Chemical; U.S. Summit |
| De-Noltab | Tripotassium Dicitratobismuthate | Astellas Pharma |
| Gastrodenol | Tripotassium Dicitratobismuthate | Astellas Pharma |
| Helinol | Tripotassium Dicitratobismuthate | Solvay |
| Helol | Tripotassium Dicitratobismuthate | Italfarmaco |
| Sucrato | Tripotassium Dicitratobismuthate | Armstrong Laboratorios de Mexico |
| Telen | Tripotassium Dicitratobismuthate | Yamanouchi |
| Trymo | Tripotassium Dicitratobismuthate | Raptakos Brett |
| Venen | Triprolidine | Unidentified Pharmaceutical Company |
| Actidil | Triprolidine Hydrochloride | GlaxoSmithKline; Pfizer |